Pregnancy and drug-induced liver injury. Case report and literature review
DOI:
https://doi.org/10.52784/27112330.123Keywords:
methimazole, pregnancy, drug-induced liver injury, toxicity.Abstract
Drug-induced liver injury (DILI) is a relative rare condition among general population and among pregnant women. It is usually underdiagnosed, and when identified, it is rarely notified to the national registry systems, especially locally, and in general in Latin America. Clinical presentation, time before symptom onset, patterns of liver injury and idiosyncratic reactions make an early diagnosis difficult, as well as the absence of diagnostic tests or histological changes that are unique to this pathology to confirm the diagnosis. We present the first case reported in the literature of a woman, who during the first trimester of pregnancy presented with DILI, secondary to the use of thionamides due to suspected hyperthyroidism.
Downloads
References
Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 2014;109:950-966; quiz 967. https://doi.org/10.1038/ajg.2014.131.
Hernández N, Bessone F, Sánchez A, di Pace M, Brahm J, Zapata R, et al. Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports. Ann Hepatol 2014;13:231-239.
Chen GC, Ramanathan VS, Law D, Funchain P, Chen GC, French S, et al. Acute liver injury induced by weight-loss herbal supplements. World J Hepatol 2010;2:410-415. https://doi.org/10.4254/wjh.v2.i11.410.
Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009;29:373-382. https://doi.org/10.1055/s-0029-1240006.
Lao TT. Drug-induced liver injury in pregnancy. Best Pract Res Clin Obstet Gynaecol 2020. In press, corrected proof. https://doi.org/https://doi.org/10.1016/j.bpobgyn.2020.03.005.
Saithanyamurthi H, Faust AJ. Drug-induced liver disease: Clinical course. Clin Liver Dis 2017;21:21-34. https://doi.org/10.1016/j.cld.2016.08.007.
Ahmad J, Odin JA. Epidemiology and genetic risk factors of drug hepatotoxicity. Clin Liver Dis 2017;21:55-72. https://doi.org/10.1016/j.cld.2016.08.004.
López-Panqueva RP. Aspectos morfológicos de la enfermedad hepática inducida por drogas. Rev Colomb Gastroenterol 2014;29:449-460. https://doi.org/10.22516/25007440.445.
Bessone F, Hernandez N, Dávalos M, Paraná R, Schinoni MI, Lizarzabal M, et al. Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative. Ann Hepatol 2012;11:544-549.
Schoepfer AM, Engel A, Fattinger K, Marbet UA, Criblez D, Reichen J, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007;47:521-526. https://doi.org/10.1016/j.jhep.2007.06.014.
López-Panqueva RP, Forero J, Sierra F. Ictericia colestásica inducida por metimazol en una paciente con hipertiroidismo. Acta Gastroenterol Latinoam 2014;44:52-58.
Zou H, Jin L, Wang LR, Braddock M, Cai WW, Zheng MH. Methimazole-induced cholestatic hepatitis: two cases report and literature review. Oncotarget 2016;7:5088-5091. https://doi.org/10.18632/oncotarget.6144.
Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. Nueva York; McGraw-Hill. 2001. p. 1825. ISBN:0071354697.
Suh JI. Drug-induced liver injury. Yeungnam Univ J Med 2020;37:2-12. https://doi.org/10.12701/yujm.2019.00297.
Andrade RJ, Aithal GP, Björnsson ES, Kaplowitz N, Kullak-Ublick GA, Larrey D, et al. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol 2019;70:1222-1261. https://doi.org/10.1016/j.jhep.2019.02.014.
Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver disease and pregnancy. Am J Gastroenterol 2016;111:176-194; quiz 196. https://doi.org/10.1038/ajg.2015.430.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
